Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit

Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit

IntroductionDexamethasone is routinely prescribed for the management of peritumoral edema in brain tumor patients. Despite available orientations for its management in neuro-oncology patients, the individual needs according to the natural history of the disease and treatment options allied to a hier...

Full description

Saved in:
Bibliographic Details
Main Authors: Vindhya Prasad, Ali Elhag, Louis Onyiriuka, Engelbert Mthunzi, Sarah Hatch, Awais Naeem, Fatmahelzahraa Noureldin, Francesco Marchi, Ahmed Raslan, Yasir A. Chowdhury, Jonathan Shapey, Richard Gullan, Ranjeev Bhangoo, Francesco Vergani, Keyoumars Ashkan, Jose Pedro Lavrador
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Neurology
Subjects:
dexamethasone
brain tumors
steroid complications
neuro-oncology
pharmacovigilance
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1632231/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1632231/full

Similar Items